Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Stopping finasteride improves sperm quality but not semen volume in young men.

Poliosis is common in severe alopecia areata but doesn't significantly affect overall prognosis.

Standardized treatment protocols are needed for children with androgenetic alopecia.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Taking photos of your own skin can lead to fewer skin biopsies for mole monitoring.

Diffuse alopecia areata in children has unique features and needs specific treatment.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Taking low-dose oral minoxidil during the day improves hair growth more than taking it at night.

Excimer laser therapy may help improve scarring alopecia symptoms and hair appearance.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Skin issues are common in people with neurodegenerative diseases.

Vaccination helps reduce long COVID symptoms in women with PCOS.

Certain medications like antipsychotics and some antidepressants increase the risk of falls in older patients.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

Baricitinib is effective for severe alopecia areata but has some side effects.

Neck burn scar contracture recurrence is more likely with larger neck defects, and closer follow-up can help detect it sooner.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.